Cong Claire Xu
EVP, Clinical Development; SVP, Clinical Development · 3 filings · Latest: Aug 30, 2026
NovaBridge Biosciences
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBP | Cong Claire Xu | EVP, Clinical Development | Aug 31, 2026 | Sale | $0.79 | 3,282 | $2.6K | 304,201 | |
NBP | Cong Claire Xu | EVP, Clinical Development | Aug 30, 2026 | Option Exercise | — | 9,382 | — | 307,483 | |
NBP | Cong Claire Xu | SVP, Clinical Development | Jul 6, 2026 | Sale | $0.89 | 4,485 | $4.0K | 298,101 | |
NBP | Cong Claire Xu | SVP, Clinical Development | Jul 4, 2026 | Option Exercise | — | 12,432 | — | 302,586 | |
NBP | Cong Claire Xu | SVP, Clinical Development | Jun 1, 2026 | Sale | $3.94 | 3,494 | $13.8K | 290,154 | |
NBP | Cong Claire Xu | SVP, Clinical Development | May 30, 2026 | Option Exercise | — | 9,382 | — | 293,648 |